PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | C0011860|type ii diabetes |
| Sentences | 1 |
| PubMedID- 23593273 | Meanwhile, data from a double blinded placebo controlled clinical study indicates that int-747 improves insulin sensitivity (http://www.interceptpharma.com/) in nonalcoholic fatty liver disease (nafld) patients with type ii diabetes. |
Page: 1